DEFINITY RT 6.52 mg/mL (Perflutren INJECTION, SUSPENSION) 6.52 mg/mL

DEFINITY RT 6.52 mg/mL is a pharmaceutical injection used for diagnostic imaging. This suspension, manufactured by Lantheus Medical Imaging, Inc., is designed to enhance ultrasound imaging for better visualization of the heart and blood vessels.

Strength

6.52 mg/mL

Pack Size

20 VIAL, GLASS in 1 CARTON (11994-017-20) / .35 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Lantheus Medical Imaging, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

DEFINITY RT is primarily used as a contrast agent in ultrasound imaging. It helps healthcare professionals obtain clearer images of the heart and blood vessels, aiding in the diagnosis of various cardiovascular conditions. The primary keyword here is 'contrast agent,' and it is often asked, 'What is DEFINITY RT used for?' This medication is administered intravenously to improve the quality of diagnostic imaging.

Side Effects

When administered, DEFINITY RT may cause common effects such as headache, nausea, or dizziness. These effects are typically mild and temporary. Some individuals may experience more severe reactions, although this is less common. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

DEFINITY RT should be handled with care, ensuring it is stored and administered according to medical guidelines. It is important to inform healthcare providers of any allergies or pre-existing conditions before use. Proper disposal of the vials is crucial to avoid contamination or accidental exposure.

Avoid Interactions

DEFINITY RT may interact with certain medications or substances. It is advisable to avoid alcohol and other contrast agents unless directed by a healthcare professional. Always disclose all current medications to your healthcare provider to minimize the risk of interactions.

Frequently Asked Questions

DEFINITY RT is used as a contrast agent to enhance ultrasound imaging of the heart and blood vessels.

DEFINITY RT is administered intravenously by a healthcare professional.

Common effects may include headache, nausea, or dizziness, which are usually mild and temporary.

It is important to consult a healthcare provider to ensure DEFINITY RT is safe to use with other medications.

DEFINITY RT should be stored according to the manufacturer's guidelines to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.